Drug resistance in malaria

Journal of Vector Borne Diseases

Volumn 41, Issue 3-4, 2004, Pages 45-53

  Farooq, Umar ^a   Mahajan, R C ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Chloroquine resistant malaria; Molecular markers; pfmdr 1 polymorphism; Sulphadoxine pyrimethamine

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISIN; CHLOROQUINE; DAPSONE; FANSIDAR; MEFLOQUINE; MULTIDRUG RESISTANCE PROTEIN; PROGUANIL; PYRIMETHAMINE; QUININE; SULFALENE; SULFAMETHOXAZOLE; TRIMETHOPRIM;

AFRICA; CAMBODIA; DRUG MECHANISM; GENE; GENETIC POLYMORPHISM; HUMAN; IN VITRO STUDY; INDIA; MALARIA; PFCRT GENE; PFMDR 1 GENE; PFMDR 2 GENE; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; REVIEW; THAILAND;

ANIMALS; ANTIMALARIALS; ATP-BINDING CASSETTE TRANSPORTERS; CHLOROQUINE; DRUG RESISTANCE; HUMANS; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; POLYMORPHISM, GENETIC; PROTOZOAN PROTEINS;

EID: 11844275347     PISSN: 09729062     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Ballou WR, Hoffman SL, Chulay JD. Safety and efficacy of a recombinant DNA. P. falciparum sporozoite vaccine. Lancet 1987; 1: 1277-81.
2. Weekly Epidemiol Rec. Geneva: World Health Organization 1996; 71: 25-32.
3. World malaria situation in 1994. Weekly Epidemiol Rec. Geneva: World Health Organization 1997; 72: 285-92.
4. World malaria situation in 1992. Weekly Epidemiol Rec. Geneva: World Health Organization 1994; 69: 309-14.
5. White NJ, Nosten F, Looaraasuwam S, Watkins WM, Marsh K, Snow RW, Kokwaro G, Ouma J, Hien TT, Molynuex ME, Taylor TE, Newbold CI, Reubush TK, Danish M, Greenwood BM, Anderson RM, Olliaro P. Averting a malaria disaster. Lancet 1999; 353: 1965-7.
6. Zucker JR, Campbell CC. Smear negative cerebral malaria due to mefloquine resistant P. falciparum acquired in the Amazone. J Infect Dis 1992; 166: 1458-9.
7. Sharma VP. Drug resistance: mechanism and management. In: Singhal Radhey L, Sood OP, editors. New Delhi: Ranbaxy Science Foundation, India 1997; p. 67-72.
8. Hastings IMF, D'Alessandro U. Modeling a predictable disaster: the rise and spread of drug resistant malaria. Parasitol Today 2000; 16: 340-7.
9. The use of antimalarial drugs. Report of an informal consultation. Geneva: World Health Organization 2001. WHO/CDS/RBM/2001.33.
10. Spencer HC. Drug resistant malaria - changing patterns mean difficult decisions. Trans R Soc Trop Med Hyg 1985; 79: 748-58.
11. Young MD, Moore DV. Chloroquine resistance in P. falciparum. Am J Trop Med Hyg 1961; 10: 317-20.
12. Wernsdorfer WH, Payne D. The dynamics of drug resistance in Plasmodium falciparum. Pharmacol Ther 1991; 50: 95-121.
13. Peters W. Resistance of human malaria I, III and IV. Chemotherapy and drug resistance in malaria, II edn. London: Academic Press 1987; p. 543-68, 593-658, 659 & 786.
14. Pickard AL, Wernsdorfer WH. Epidemiology of drug-resistant malaria. Lancet Infect Dis 2002; 2: 209-18.
15. Trape JF. The public health impart of chloroquine resistance in Africa. Am J Trop Med Hyg 2001; 64: 12-7.
16. Landgraf B, Kollaritsch H, Wiedermann G, Wernsdorfer WH. Plasmodium falciparum: successfully in vitro and in vivo to chloroquine and sulfadoxine-pyrimethamine in Ghanaian school children. Trans R Soc Trop Med Hyg 1994; 88: 440-2.
17. Ringwald P, Same Ekobo A, Keundjian A, Kedy Mangamba D, Basco LK. Chemo-resistance of P. falciparum in urban areas of Yaounde, Cameroon: pt I, surveillance of in vitro and in vivo resistance of Plasmodium falciparum to chloroquine from 1994 to 1999 in Yaounde, Cameroon. Trop Med Intl Health 2000; 5: 612-9.
18. Djimde A, Doumbo OK, Cortese JF, Kayentao K, Doumbo S, Diourte Y, Dicko A, Su XZ, Nomura T, Fidock DA, Wellems TE, Plowe CV, Coulibaly D. A molecular marker for chloroquine resistant falciparum malaria. New England J Med 2001; 344: 257-63.
19. Sehgal PN, Sharma, MID, Sharma SI, Gopal S. Resistance to chloroquine in falciparum malaria in Assam state, India. J Com Dis 1973; 5: 175-80.
20. Clyde DF. Variations in response of malaria parasites to drugs in Asia and Oceania. La Medicina Tropicals 1987; 3: 3-21.
21. Venna, SC, Mahajan RC, Prasad RN, Kumar S, Ganguly NK, Sharma BK. Chloroquine resistant falciparum malaria in Punjab (Northern India). Trans R Soc Trop Med Hyg 1986; 80: 489.
22. Rieckman KH, Davis DR, Hutton DC. Plasmodium vivax resistance chloroquine? Lancet 1989; 2: 1183-4.
23. Potkar CN, Kashersagar NA, Kathwria R. Resurgence of malaria and drug resistance in P. falciparum and P. vivax species in Bombay. J Assoc Phys India 1994; 43: 336-8.
24. Garg N, Gopinath P, Bodhe P, Kshersagar A. Vivax malaria resistant to chloroquine: case reports from Bombay. Trans R Soc Trop Med Hyg 1995; 89: 656-7.
25. Dua VK, Kar PK, Sharma VP. Chloroquine resistant P. vivax in India. Trop Med Intl Hlth 1996; 1: 816-9.
26. Adak T, Sharma VP, Orlov VS. Studies on P. vivax relapse pattern in Delhi. Am J Trop Med Hyg 1978; 59: 175-9.
27. Winstaneley P. Modern chemotherapeutic options for malaria. Lancet Infect Dis 2001; 1: 1-19.
28. Bjorkman A, Phillips-Howard PA. The epidemiology of drug-resistant malaria. Trans R Soc Trop Med Hyg 1990; 84: 177-80.
29. Aramburu JG, Ramal Asayag C, Witzig R. Malaria re-emergence in the Peruvian Amazon region. Emerg Infect Dis 1999; 5: 209-15.
30. Vasconcelos KF, Plowe CV, Fontes CJ, Kyle D, Wirth DF, Pereira da Silva LH, Zalis MG. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase of isolates from the Amazon region of Brazil. Mem Inst Oswaldo Cruz 2000; 95: 721-8.
31. Bloland P. Drug resistance in malaria. Geneva: WHO 2001. WHO/CDS/CSR/DRS/2001.4.
32. Ronn AM, Msangeni HA, Mhina J, Wernsdoner WH, Bygbjerg IC. High level of resistance of Plasmodium falciparum to sulfadoxine-pyremethamine in children in Tanzania. Trans R Soc Trop Med Hyg 1996; 90: 179-81.
33. Choudhury DS, Sinha S, Ghosh SK, Usha Devi C, Sharma VP. Report of a case of P. falciparum malaria resistant to chloroquine and combination of sulfalene and pyrimethamine in Delhi. Indian J Med Res 1987; 24: 95-6
34. Zalis MG, Pang L, Silveira MS, Milhous WK, Wirth DF. Characterization of Plasmodium falcipantm isolated from the Amazon region of Brazil: evidence of quinine resistance. Am J Trop Med Hyg 1998; 58: 630-7.
35. Jelinek T, Grobusch MP, Loscher T. Patterns of Plasmodium falciparum drug resistance in non immune travellers to Africa. European J Clin Microbiol Infect Dis 2001; 20: 284-6.
36. Wernsdorfer WH. Epidemiology of drug resistance in malaria. Acta Trop 1994; 56: 143-56.
37. Mishra SP. In vivo resistance to chloroquine and sulphapyrimethamine combination in P. falciparum in India. Proceedings of National Academy of Sciences, India 1996; 66: 123-8.
38. Wongsrichanalai C, Sirichaisinthop J, Karwack JJ, Congpuong K, Miller RS, Pang L, Thimasam K. Drug resistant malaria on the Thai-Myanmar and Thai-Cambodian borders. Southeast Asian J Med Pub Hlth 2001; 32: 41-9.
39. Shanks GD. The rise and fall of mefloquine as an antimalarial drug in southeast Asia. Military Med 1994; 159: 275-81.
40. Muckenhaupt FP. Mefloquine resistance in Plasmodium falciparum. Parasitol Today 1995; 11: 248-53.
41. Sharma VP. Re-emergence of malaria in India. Indian J Med Res 1996; 103: 26-45.
42. Resistance of malaria parasites to drug. WHO Tech Rep Ser. Geneva: World Health Organization 1965; 296: 29.
43. White NJ. Assessment of the pharmacodynamic properties of antimalarial drugs in-vivo. Antimicrobial Agents Chemother 1997; 421: 1413-22.
44. Schapira A, Almeida Franco LT, Averkiev L, Omawale, Schwalbach JF, Suleimanov G. The Plasmodium falciparum chloroquine in vivo test: extended follow-up is more important than parasite counting. Trans R Soc Trop Med Hyg 1988; 82(1): 39-43.
45. Bruce-Chwatt LJ. Chemotherapy of malaria. Geneva: World Health Organization 1986.
46. The biology of malaria parasites. Report of a WHO Scientific Group. WHO Tech Rep Ser 1987.
47. Yamanda KA, Sherman IWP. Cophurae-composition and properties of haemazione, the malaria pigment. Exp Parasitol 1979; 48.
48. Krogstad DJ, Gluzman IY, Kyle DE, Odoula AM, Martin SK, Milhous WK, Schlesinger PH. Efflux of chloroquine from P. falciparum: mechanism of chloroquine resistance. Science 1987; 238: 1283-5.
49. Geary TG, Jenson JB, Ginsburg J. Uptake of [3H] chloroquine by drug-sensitive and -resistant strains of human malaria parasite P. falciparum. Biochem Pharmacol 1986; 35(21): 3805-12.
50. Foley M, Tilley L. Quinoline antimalarials mechanisms of action and resistance. Intl J Parasitol 1997; 27: 231-40.
51. Martin SK, Oduola AM, Milbous WK. Reversal of chloroquine resistance in Plasmodium falciparum by verapamil. Science 1987; 235 (4791): 899-901.
52. Von Seidlein L, Duraisingh MT, Drakeley CJ, Bailey R, Greenwood BM, Pinder M. Polymorphism of the pfmdr-1, gene and chloroquine resistance in Plasmodium falciparum in the Gambia. Trans R Soc Trop Med Hyg 1997; 91: 450-3.
53. Povoa MM, Adagu IS, Oliveira SG, Machado RL, Miles MA, Warhurst DC. Pfmdr-1 Asn 1042 sp and Asp 1246 Tyr polymorphisms, thought to be associated with chloroquine resistance, are present in chloroquine-resistant and -sensitive Brazilian field isolates of Plasmodium falciparum. Exp Parasitol 1998; 88: 64-8.
54. Price RN, Cassar C, Brockman A, Duraisingh M, van Vugt M, White NJ, Nosten F, Krishna S. The pfmdr-1 gene is associated with a multidrug-resistant phenotype in Plasmodium falciparum from the western border of Thailand. Antimicrob Agents Chemother 1999; 43: 2943-9.
55. Babiker HA, Pringle SJ, Abdel-Muhsin A, Mackinnon M, Hunt P, Walliker D. High level chloroquine resistance in Sudanese isolates of P. falciparum is associated with mutations in the chloroquine resistance transporter gene pfcrt and the multidrug resistance gene pfmdr-1. J Infect Dis 2001; 183: 1535-8.
56. Fidock DA, Nomura T, Talley AK, Cooper RA, Dzekunov SM, Ferdig MT, Ursos LM, Sidhu AB, Naude B, Deitsch KW, Su XZ, Wotton JC, Roepe PD, Wellems TE. Mutations in the P. falciparum digestive vacuole transmembrane protein pfcrt and evidence for their role in chloroquine resistance. Mol Cell 2000; 6: 861-71.
57. Durand R, Jafari S, Vauzelle J, Delabre JF, Jesic ZZ, Le Bras J. Analysis of pfcrt point mutations and chloroquine susceptibility in isolates of Plasmodium falciparum. Mol Biochem Parasitol 2001; 114: 95-102.
58. Ferone R. Dihydrofolate reductase from pyrimethamine-resistant P. berghei. J Biol Chem 1970; 245 (4): 850-4.
59. Nagesha HS, Din S, Casey GJ, Susanti AI, Fryauff DJ, Reeder JC, Cowman AF. Mutations in the pfmdr-1, dhfr and dhps genes of Plasmodium falciparum are associated with in vivo drug resistance in West Papua Indonesia. Trans R Soc Trop Med Hyg 2001; 95: 43-9.
60. Plowe CV, Cortese JF, Djimde A, Nwanyanwu OC, Watkins WM, Winstanley PA, Estrada-Franco JG, Mollinedo RE, Avila JC, Cespedes JL, Carter D, Doumbo OK. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiolgic patterns of pyrimethamine-sulfadoxine use and resistance. J Infect Dis 1997; 176: 1590-6.
61. Mawili-Mboumba DP, Ekala MT, Lekoulou F, Ntoumi F. Molecular analysis of DHFR and DHPS genes in Plasmodium falciparum clinical isolates from the Haut-Ogooue region in Gabon. Acta Trop 2001; 78: 231-40.
62. Urdaneta L, Flowe C, Goldman I, Lal AA. Point mutations in dihyrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum isolates from Venezuela. Am J Trop Med Hyg 1999; 61: 457-62.
63. Basco LK, Le Bras J, Rhoades Z, Wilson CM. Analysis of pfmdr-1 and drug susceptibility in fresh isolates of Plasmodium falciparum from sub-Saharan Africa. Mol Biochem Parasitol 1995; 74: 157-66.
64. Duraisingh MT, Jones P, Sambou I, Von Seidlein L, Pinder M, Warhurst DC. The tyrosine-86 allele of pfmdr-1 gene of Plasmodium falciparum is associated with increased sensitivity to the antimalarials mefloquine and artemisinin. Mol Biochem Parasitol 2000; 108: 13-23.
65. Reed ME, Saliba KJ, Caruana SR, Kirk K, Cowman AF. Pgh 1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature 2000; 403: 906-9.